Extracts from CBD- and CBG-rich material, supplied to licensed pharmaceutical and industrial buyers. We have already exported THC and CBD extracts to Brazil. Specifications and cannabinoid content are stated per batch on the certificate of analysis.
Alongside our resins, we supply extracts from CBD- and CBG-rich material to licensed pharmaceutical and industrial partners. Extract specifications are agreed per project and documented per batch.
We have already exported THC and CBD extracts to Brazil, and THC and CBD resin to Switzerland, and we have established export operations to Lesotho. Every shipment runs under our ANRAC export authorisation 54/A8/0223, with the regulatory paperwork and transport handled by our team up to the buyer's customs clearance point.
| Parameter | CBD & CBG extracts |
|---|---|
| Source material | CBD- and CBG-rich cannabis |
| Buyers | Licensed pharmaceutical and industrial partners |
| Cannabinoid content | Per batch, on the COA |
| Specification | Agreed per project |
The cultivation behind our production is covered by the LSQA WHO-GACP Declaration of Conformity PP90/01 (Level A), whose scope includes CBD strains. Processing is authorised under ANRAC 52/A5/0223. We are advancing toward EU-GMP certification. Where a buyer needs EU-GMP material today, conversion is carried out by our partners in Switzerland and Portugal.
To discuss a specification, apply for trade access or contact the export desk.
Yes. We have exported THC and CBD extracts to Brazil.
Licensed pharmaceutical and industrial buyers. Access to specifications and pricing is given after we review your licence: apply for trade access.
Specifications and cannabinoid content are stated per batch on the certificate of analysis.